Albenza Tablets News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Mumbai, Apr 30: Pharma Major, Dr Reddy's Labs announced the launch of Albendazole Tablets, USP, a therapeutic equivalent generic version of Albenza

Dr. Reddy's Laboratories share rises over 2% on launch of Albendazole tablets The large cap stock rose 2.15% to Rs 5,210 today against previous close of Rs 5,102 on BSE BusinessToday.In | April 30, 2021 | Updated 14:08 IST Albendazole is an anthelmintic drug indicated for the treatment of parenchymal neurocysticercosis due to active lesions caused by larval forms of the pork tapeworm, Taenia solium. Share of Dr. Reddy's Laboratories rose over 2% in trade today after the company launced Albendazole Tablets, USP, a therapeutic equivalent generic version of Albenza Tablets, 200 mg, approved by ...

Nifty to tumble over 130 points on weak global cues April 30, 2021 Spotlight will be on quarterly results and progress of Covid-19 vaccination Indian markets are expected to open slightly lower on Friday, amidst weak global cues emanated from Asian markets. The SGX Nifty, which currently rules at 14,770 at the Singapore Stock Exchange, indicates at least 130 points gap-down opening for Nifty futures, which on Friday closed at 14,901. According to analysts, the focus will be on progress in Covid pandemic and corporate results. Though the US market closed on strong note overnight, Asian mark...

Food and Drug Administration (USFDA). The Albenza brand and generic had U. S. sales of approximately $27 million MAT for the most recent twelve months ending in November 2020 according to IQVIA Health. Dr. Reddy's Albendazole Tablets, USP are available in 200 mg tablets in bottle count sizes of two. Albenza is a trademark of GlaxoSmithKline. Powered by Capital Market - Live News (This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.) Dear Reader, Business Standard has always strived hard to provide up-to-date information and commentary on ...